Literature DB >> 17054550

Tumour size as a predictor of axillary node metastases in patients with breast cancer.

Sharon Laura1, Nathan J Coombs, Owen Ung, John Boyages.   

Abstract

BACKGROUND: The ability to predict the behaviour of breast cancer from its dimensions allows the clinician to inform a woman about the absolute benefits of adjuvant therapies or further surgery to control her disease. Tumour size and grade are independent predictors of nodal disease. This study aims to generate a tool, using Australian data, allowing surgeons to calculate the probability of axillary lymph node involvement in a preoperative setting.
METHODS: The histological reports of patients with breast cancer treated in 1995 in New South Wales were examined and tumour size, grade and nodal status recorded. Univariate and multivariate analyses identified predictors of node positivity and, using linear regression analysis, a simple formula to predict nodal involvement was derived.
RESULTS: In a 6-month period, 754 women had non-metastatic, unifocal breast cancer treated with surgery and complete axillary dissection and 283 (37.5%) had positive nodes. Tumour size remained an independent predictor of node positivity and the probability (%), y, of nodal involvement may be predicted by the formula y = 1.5 x tumour size (mm) + 7, r = 0.939 and P = 0.001.
CONCLUSIONS: This paper shows the need to assess the axilla in every patient because even patients with small tumours (0-5 mm) have the possibility of axillary involvement (7-14.5%). Use of this simple formula allows clinicians and patients to make informed decisions about the possible need for a full axillary dissection to reduce the chance of understaging and potentially undertreating a woman's breast cancer.

Entities:  

Mesh:

Year:  2006        PMID: 17054550     DOI: 10.1111/j.1445-2197.2006.03918.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  11 in total

1.  Level of education, background and clinical stage as prognostic factors according to RMST function in patients with early and locally advanced breast cancer: a single institution experience from Romania.

Authors:  Irina Niţă; Cornelia Niţipir; Ştefania Andreea Toma; Alexandra Maria Limbău; Edvina Pirvu; Ioana Anca Bădărău; Ioana Suciu; George Suciu; Loredana Sabina Cornelia Manolescu
Journal:  Med Pharm Rep       Date:  2022-01-31

2.  Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis.

Authors:  H Verry; S J Lord; A Martin; G Gill; C K Lee; K Howard; N Wetzig; J Simes
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640

3.  Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia.

Authors:  Sumadi Lukman Anwar; Widya Surya Avanti; Andreas Cahyo Nugroho; Lina Choridah; Ery Kus Dwianingsih; Wirsma Arif Harahap; Teguh Aryandono; Wahyu Wulaningsih
Journal:  World J Surg Oncol       Date:  2020-05-30       Impact factor: 2.754

4.  Electric Fields at Breast Cancer and Cancer Cell Collective Galvanotaxis.

Authors:  Kan Zhu; Nicholas R Hum; Brian Reid; Qin Sun; Gabriela G Loots; Min Zhao
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

5.  Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study.

Authors:  Nobuaki Sato; Norikazu Masuda; Takashi Morimoto; Takayuki Ueno; Chizuko Kanbayashi; Koji Kaneko; Hiroyuki Yasojima; Shigehira Saji; Hironobu Sasano; Satoshi Morita; Shinji Ohno; Masakazu Toi
Journal:  Cancer Med       Date:  2019-07-30       Impact factor: 4.452

6.  Clinicopathological Characteristics and Treatment Strategies of Triple-Negative Breast Cancer Patients With a Survival Longer than 5 Years.

Authors:  Ning Xie; Ying Xu; Ying Zhong; Junwei Li; Herui Yao; Tao Qin
Journal:  Front Oncol       Date:  2021-02-01       Impact factor: 6.244

Review 7.  Bioelectric Dysregulation in Cancer Initiation, Promotion, and Progression.

Authors:  Maulee Sheth; Leyla Esfandiari
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

8.  Correlation between Duffy blood group phenotype and breast cancer incidence.

Authors:  Xiao-Feng Liu; Lian-Fang Li; Zhou-Luo Ou; Rong Shen; Zhi-Min Shao
Journal:  BMC Cancer       Date:  2012-08-28       Impact factor: 4.430

9.  Tumour location within the breast: Does tumour site have prognostic ability?

Authors:  Seth Rummel; Matthew T Hueman; Nick Costantino; Craig D Shriver; Rachel E Ellsworth
Journal:  Ecancermedicalscience       Date:  2015-07-13

10.  The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.

Authors:  Victoria Sopik; Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2018-04-24       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.